| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8753214 | Annals of Epidemiology | 2018 | 10 Pages |
Abstract
Health care appears to be the primary driver of prevalent (and possibly incident) infections in MENA, followed by injecting drug use. HCV screening should target the identified modes of exposure. Commitment to prevention should be an integral component of HCV response to achieve HCV elimination by 2030, with focus on strengthening infection control in health care facilities, improving injection safety and blood screening, and expanding harm reduction services for people who inject drugs.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Sarwat MPH, Silva P. MSc, Zaina PhD, Hiam MSc, Laith J. PhD,